Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Availability Heuristic

The Availability Heuristic

A heuristic is a general problem-solving framework (Tversky & Kahneman, 1974). You can think of these as mental shortcuts that are used to solve problems. Different types of heuristics are used in different types of situations, and the impulse to use a heuristic occurs when one of five conditions is met (Pratkanis, 1989):

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Allogeneic haematopoietic stem cell transplantation in myelofibrosis: Patient selection, pre-transplant preparation and harmonisation of practices (SFGM-TC)].

Bulletin du cancer·2026

Same author

Impaired iron balance and erythrocytosis: a complex relationship.

Blood cancer journal·2026

Same author

Unraveling the role of <i>TP53</i> mutations in myeloproliferative neoplasms: Molecular mechanisms of leukemic transformation.

HemaSphere·2026

Same author

IFN-I-Mediated Transcriptional Reprogramming Drives Myeloid-Skewed Hematopoiesis in Sickle Cell Anemia.

American journal of hematology·2026

Same author

Characteristics and prognostic significance of myelodysplasia-related features in VEXAS syndrome.

Leukemia·2026

Same author

Next-generation JAK inhibitors in the treatment of myeloproliferative neoplasms.

Blood·2026

Same journal

[ONCONNECTE À L'EMPLOI, feedback after three years of a program to prepare for returning to work after cancer in Franche-Comté].

Bulletin du cancer·2026

Same journal

[Off-label use of venetoclax in myeloma].

Bulletin du cancer·2026

Same journal

[Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

Bulletin du cancer·2026

Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026

Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026

Same journal

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 16, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

[Not Available].

Matthieu Mosca¹, Gaëlle Vertenoeil², Katte Rao Toppaldoddi¹

¹Inserm UMR 1170, Gustave Roussy, Villejuif, 94805, France; Université Paris-Saclay, UMR 1170, Gustave Roussy, Villejuif, 94805, France; Gustave Roussy, UMR 1170, Villejuif, 94805, France.

Bulletin Du Cancer

|August 7, 2016

Summary

This summary is machine-generated.

Myeloproliferative neoplasms (MPN) are clonal stem cell disorders driven by mutations affecting the JAK/STAT pathway. Therapies targeting JAK2 signaling show promise for managing these conditions.

Keywords:

Calreticulin Calréticuline Epigenetic mutations JAK2V617F MPL Mutations Myeloproliferative Néoplasmes d'épigénétique myéloprolifératifs neoplasms

More Related Videos

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

Related Experiment Videos

Last Updated: Mar 16, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

Area of Science:

Hematology
Molecular Biology
Oncology

Background:

Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell disorders.
Classical MPNs include polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
These BCR-ABL-negative disorders involve abnormal myeloid cell production.

Purpose of the Study:

To explore the biological underpinnings of JAK/STAT signaling in BCR-ABL-negative MPNs.
To understand the role of key genetic mutations in MPN pathogenesis.
To review current and emerging therapeutic strategies.

Main Methods:

Analysis of genetic mutations (JAK2, MPL, CALR) in MPN patients.
Review of signaling pathway dysregulation.
Examination of therapeutic interventions targeting JAK2.

Main Results:

Approximately 90% of MPNs are associated with JAK2, MPL, or CALR mutations.
These mutations lead to the deregulation of the cytokine receptor/JAK2/STAT axis.
Associated risks include thrombosis, hemorrhage, cytopenias, myelofibrosis, and leukemia transformation.

Conclusions:

Targeting the JAK2 signaling pathway is a key therapeutic strategy for MPNs.
Interferon-alpha can induce hematologic and molecular remission in some patients.
Understanding JAK/STAT signaling is crucial for MPN management.